Diabetes

Novo Nordisk India launches oral formulation to treat diabetes

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), is indicated for the management of type 2 diabetes.

Read more at www.biospectrumindia.com

Show More

Related Articles

Back to top button